Annual EBITDA
$1.81B$465.50M+34.59%
Summary
- Current Value
- As of today, LH annual EBITDA is $1.81B, up +34.59% on
- Historical Performance
- LH annual EBITDA is down -50.73% over the past 3 years, and down -5.80% over the past 5 years
- All-Time High Comparison
- LH annual EBITDA is currently -50.73% below its historical high of $3.68B set on
- 3-Year Low Comparison
- LH annual EBITDA is +34.59% above its 3-year low of $1.35B reached on
- Sector Comparison
- LH annual EBITDA is higher than 95.76% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.81B | +34.6% | -50.7% | -5.8% | +58.5% | |
| Quarterly EBITDA | $574.20M | +32.4% | +2.6% | -55.0% | +91.0% | |
| TTM EBITDA | $2.04B | +16.1% | -34.0% | -24.4% | +71.9% | |
| Price | $270.87 | +13.4% | +25.3% | +40.9% | +245.9% | |
| PE Ratio | 26.60 | -1.6% | +70.3% | +118.9% | +80.3% | |
| Annual Revenue | $13.01B | +7.0% | -19.3% | +12.6% | +177.1% | |
| Annual EPS | $8.84 | +85.2% | -63.8% | +5.8% | +77.5% | |
| Annual EBIT | $1.17B | +52.0% | -62.3% | -13.2% | +23.3% | |
| Annual Net Income | $747.10M | +96.4% | -68.6% | -9.4% | +34.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.95B | N/A | -7.3% |
| 5Y | $3.68B | -50.7% | |
| All | $3.68B | -50.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.35B | +34.6% | |
| 5Y | $1.35B | +34.6% | |
| All | $17.50M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of LH?
As of today, LH annual EBITDA is $1.81B
What is 1-year change in LH annual EBITDA?
LH annual EBITDA is up +34.59% year-over-year
What is 3-year change in LH annual EBITDA?
LH annual EBITDA is down -50.73% over the past 3 years
How far is LH annual EBITDA from its all-time high?
LH annual EBITDA is currently -50.73% below its historical high of $3.68B set on December 31, 2021
How does LH annual EBITDA rank versus sector peers?
LH annual EBITDA is higher than 95.76% of companies in Healthcare sector
When is LH next annual earnings release?
The next annual earnings release for LH is on
Quarterly EBITDA
$574.20M$5.30M+0.93%
Summary
- Current Value
- As of today, LH quarterly EBITDA is $574.20M, up +0.93% on
- Historical Performance
- LH quarterly EBITDA is up +32.43% year-over-year, and up +2.63% over the past 3 years
- All-Time High Comparison
- LH quarterly EBITDA is currently -62.66% below its historical high of $1.54B set on
- 3-Year Low Comparison
- LH quarterly EBITDA is +51.38% above its 3-year low of $379.30M reached on
- Sector Comparison
- LH quarterly EBITDA is higher than 95.66% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $574.20M | +0.9% | +32.4% | +2.6% | -55.0% | |
| Annual EBITDA | $1.81B | – | +34.6% | -50.7% | -5.8% | |
| TTM EBITDA | $2.04B | +7.4% | +16.1% | -34.0% | -24.4% | |
| Price | $270.87 | -4.5% | +13.4% | +25.3% | +40.9% | |
| PE Ratio | 26.60 | -4.5% | -1.6% | +70.3% | +118.9% | |
| Quarterly Revenue | $3.56B | +1.0% | +8.6% | +24.3% | -8.5% | |
| Quarterly EPS | $3.12 | +10.0% | +55.5% | -19.8% | -56.5% | |
| Quarterly EBIT | $403.20M | +1.1% | +48.2% | +5.0% | -62.6% | |
| Quarterly Net Income | $261.50M | +9.7% | +54.2% | -5.7% | -62.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $574.20M | at high | |
| 3Y | $574.20M | at high | |
| 5Y | $1.54B | N/A | -62.7% |
| All | $1.54B | -62.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $401.30M | N/A | +43.1% |
| 3Y | $379.30M | +51.4% | |
| 5Y | $379.30M | +51.4% | |
| All | -$132.70M | +532.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of LH?
As of today, LH quarterly EBITDA is $574.20M
What is LH quarterly EBITDA most recent change?
LH quarterly EBITDA was up +0.93% on September 30, 2025
What is 1-year change in LH quarterly EBITDA?
LH quarterly EBITDA is up +32.43% year-over-year
How far is LH quarterly EBITDA from its all-time high?
LH quarterly EBITDA is currently -62.66% below its historical high of $1.54B set on December 31, 2020
How does LH quarterly EBITDA rank versus sector peers?
LH quarterly EBITDA is higher than 95.66% of companies in Healthcare sector
When is LH next earnings release?
The next earnings release for LH is on
TTM EBITDA
$2.04B$140.60M+7.39%
Summary
- Current Value
- As of today, LH TTM EBITDA is $2.04B, up +7.39% on
- Historical Performance
- LH TTM EBITDA is up +16.15% year-over-year, and down -33.99% over the past 3 years
- All-Time High Comparison
- LH TTM EBITDA is currently -59.71% below its historical high of $5.07B set on
- 3-Year Low Comparison
- LH TTM EBITDA is +16.15% above its 3-year low of $1.76B reached on
- Sector Comparison
- LH TTM EBITDA is higher than 95.57% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.04B | +7.4% | +16.1% | -34.0% | -24.4% | |
| Annual EBITDA | $1.81B | – | +34.6% | -50.7% | -5.8% | |
| Quarterly EBITDA | $574.20M | +0.9% | +32.4% | +2.6% | -55.0% | |
| Price | $270.87 | -4.5% | +13.4% | +25.3% | +40.9% | |
| PE Ratio | 26.60 | -4.5% | -1.6% | +70.3% | +118.9% | |
| TTM Revenue | $13.77B | +2.1% | +8.3% | +0.1% | +10.6% | |
| TTM EPS | $10.18 | +12.3% | +97.2% | -45.6% | +18.5% | |
| TTM EBIT | $1.36B | +10.6% | +20.1% | -41.2% | -32.1% | |
| TTM Net Income | $856.40M | +12.0% | +96.1% | -46.2% | +1.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.04B | at high | |
| 3Y | $2.60B | N/A | -21.4% |
| 5Y | $5.07B | -59.7% | |
| All | $5.07B | -59.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.78B | N/A | +14.7% |
| 3Y | $1.76B | +16.1% | |
| 5Y | $1.76B | +16.1% | |
| All | $17.60M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of LH?
As of today, LH TTM EBITDA is $2.04B
What is LH TTM EBITDA most recent change?
LH TTM EBITDA was up +7.39% on September 30, 2025
What is 1-year change in LH TTM EBITDA?
LH TTM EBITDA is up +16.15% year-over-year
How far is LH TTM EBITDA from its all-time high?
LH TTM EBITDA is currently -59.71% below its historical high of $5.07B set on June 30, 2021
How does LH TTM EBITDA rank versus sector peers?
LH TTM EBITDA is higher than 95.57% of companies in Healthcare sector
When is LH next earnings release?
The next earnings release for LH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- LH Official Website www.labcorp.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/920148/000092014825000093/0000920148-25-000093-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/920148/000092014825000032/0000920148-25-000032-index.htm
- LH Profile on Yahoo Finance finance.yahoo.com/quote/LH
- LH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lh